CMV retinitis screening and treatment in a resource-poor setting: three-year experience from a primary care HIV/AIDS programme in Myanmar

被引:26
作者
Tun, NiNi [2 ]
London, Nikolas [3 ]
Kyaw, Moe Kyaw [4 ]
Smithuis, Frank [2 ]
Ford, Nathan [5 ,6 ]
Margolis, Todd [7 ]
Drew, W. Lawrence [7 ]
Lewallen, Susan [8 ]
Heiden, David [1 ,9 ]
机构
[1] Calif Pacific Med Ctr, San Francisco, CA 90000 USA
[2] Med Act Myanmar, Yangon 11000, Myanmar
[3] Wills Eye Inst, Retina Serv, Philadelphia, PA 19107 USA
[4] Med Sans Frontieres OCA, Yangon 11000, Myanmar
[5] Med Sans Frontieres, London EC1N 8QX, England
[6] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa
[7] Univ Calif San Francisco, San Francisco, CA 94143 USA
[8] Kilimanjaro Ctr Community Ophthalmol, Moishe, Tanzania
[9] Seva Fdn, Berkeley, CA 94710 USA
关键词
HIV-INFECTED PATIENTS; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; CYTOMEGALOVIRUS RETINITIS; OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY; RISK-FACTORS; DISEASE; AIDS;
D O I
10.1186/1758-2652-14-41
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Cytomegalovirus retinitis is a neglected disease in resource-poor settings, in part because of the perceived complexity of care and because ophthalmologists are rarely accessible. In this paper, we describe a pilot programme of CMV retinitis management by non-ophthalmologists. The programme consists of systematic screening of all high-risk patients (CD4 <100 cells/mm(3)) by AIDS clinicians using indirect ophthalmoscopy, and treatment of all patients with active retinitis by intravitreal injection of ganciclovir. Prior to this programme, CMV retinitis was not routinely examined for, or treated, in Myanmar. Methods: This is a retrospective descriptive study. Between November 2006 and July 2009, 17 primary care AIDS clinicians were trained in indirect ophthalmoscopy and diagnosis of CMV retinitis; eight were also trained in intravitreal injection. Evaluation of training by a variety of methods documented high clinical competence. Systematic screening of all high-risk patients (CD4 <100 cells/mm(3)) was carried out at five separate AIDS clinics throughout Myanmar. Results: A total of 891 new patients (1782 eyes) were screened in the primary area (Yangon); the majority of patients were male (64.3%), median age was 32 years, and median CD4 cell count was 38 cells/mm(3). CMV retinitis was diagnosed in 24% (211/891) of these patients. Bilateral disease was present in 36% of patients. Patients with active retinitis were treated with weekly intravitreal injection of ganciclovir, with patients typically receiving five to seven injections per eye. A total of 1296 injections were administered. Conclusions: A strategy of management of CMV retinitis at the primary care level is feasible in resource-poor settings. With appropriate training and support, CMV retinitis can be diagnosed and treated by AIDS clinicians (non-ophthalmologists), just like other major opportunistic infections.
引用
收藏
页数:6
相关论文
共 19 条
  • [1] [Anonymous], 2009, MMWR RECOMM REP
  • [2] [Anonymous], 2008, Hepatitis B. Fact sheet no. 204, P1
  • [3] Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55
  • [4] Prognostic factors of survival of HIV-infected patients with cytomegalovirus disease: Aquitaine Cohort, 1986-1997
    Binquet, C
    Saillour, F
    Bernard, N
    Rougier, MB
    Leger, F
    Bonnal, F
    Dabis, F
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2000, 16 (05) : 425 - 432
  • [5] DREW WL, 2007, GLOBAL HIV AIDS MED, P437
  • [6] Cytomegalovirus retinitis: The neglected disease of the AIDS pandemic
    Heiden, Daivd
    Ford, Nathan
    Wilson, David
    Rodriguez, William R.
    Margolis, Todd
    Janssens, Bart
    Bedelu, Martha
    Tun, Nini
    Goemaere, Eric
    Saranchuk, Peter
    Sabapathy, Kalpana
    Smithuis, Frank
    Luyirika, Emmanuel
    Drew, W. Lawrence
    [J]. PLOS MEDICINE, 2007, 4 (12): : 1845 - 1851
  • [7] Holbrook JT, 2003, ARCH OPHTHALMOL-CHIC, V121, P99
  • [8] Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome
    Jacobson, MA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (02) : 105 - 114
  • [9] Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1
  • [10] Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome
    Kempen, JH
    Jabs, DA
    Wilson, LA
    Dunn, JP
    West, SK
    Tonascia, J
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 (10) : 1365 - 1373